Vorschau: EBSIN Spring 2025_Automation

European Biotechnology Spring 2025

Official Media Partner of

Preview Spring 2025

© rookielion - stock.adobe.com

Technology + System Integration SPECIAL

Publication date: 20 March, 2025

New Lab Automation Section!

Hot topics in technology and process integration The integration of licensed, newly developed technologies into automated environments used by established laboratory equipment suppliers and drug screening service providers is driving progress in drug screening and the growth of the lab automation sector: while start-ups and academic collaborators generate heart organoids from pluripotent stem cells, for example, organoid-based drug screening is only made possible by AIcontrolled systems for fully automated organoid culture. But this is just one example of technology and data integration. In collaboration with the Society for Laboratory Automation & Screening (SLAS), the special ‘Technology and Process Integration’ offers the opportunity to present your innovations, joint product developments and services in an exciting editorial environment, just in time for SLAS Europe 2025 (20-22 May, Hamburg).

Present your expertise

Drug developers, CROs, bioprocess developers, analytical experts, formulation and drug delivery specialists, providers of research equipment, AI and ML companies, as well as lab automation experts will have the opportunity to present their latest developments, products, services, and equipment in this special.

European Biotechnology goes out to decision makers throughout the entire European Life Sciences sector. Take advantage of the journal’s highly relevant readership and grab this opportunity to target your audience!

Topics to be covered Process and technology integration/services: Automated culture of adherently growing or cryopreserved cells, assay-based testing of novel modalities such as condensates, RNA drugs, conjugates, engineered cell and antibody therapies and iterative AI-guided optimisation, automated manufacturing, AI-guided process development, analytical testing, formulation and optimisation, quality assurance, delivery strategies, equipment etc.

Editorial Deadline 07-03-2025

Booking Deadline 07-03-2025

Publication Date 20-03-2025

Editorial Contact: Thomas Gabrielczyk Tel.: +49-30-264921-50 Fax: +49-30-264921-11 t.gabrielczyk@biocom.de

Marketing Contact: Oliver Schnell Tel.: +49-30-264921-45 Fax: +49-30-264921-11 o.schnell@biocom.de

Marketing Contact: Andreas Macht Tel.: +49-30-264921-54 Fax: +49-30-264921-11 a.macht@biocom.de

BIOCOM Interrelations GmbH I Jacobsenweg 61 I 13509 Berlin I www.biocom.de

Special: Technology & System Integration

Meet your audience!

European Biotechnology is published in co-operation with the following organisations: European Biotechnology Net work

Young European Biotech Network

Europe: european-biotechnology.net

Europe: yebn.eu

Austria: lifescienceaustria.at

Austria: biotechaustria.org

United States: slas.org

Europe: medicinesforeurope.com

Ireland: ibec.ie/ibia

Denmark: danskbiotek.dk

The Netherlands: hollandbio.nl

Germany: gasb.de

Portugal: www.p-bio.org

UK: biopartner.co.uk

France: france-biotech.org

Italy: assobiotec.federchimica.it

Sweden: swedenbio.com

Hungary: hungarianbiotech.org

Europe: cebr.net

Spain: asebio.com

Norway: bioteknologiradet.no

Finland: suomenbioteollisuus.fi

Belgium: bio.be

Switzerland: swissbiotech.org

European Biotechnology covers the biotechnology sector of the current 27 EU member states, Norway, Switzerland, and UK. If you would like to subscribe, please refer to european-biotechnology.com